ICON today announced that it has appointed Mr. Manuel Ploch as General Manager, Japan.
ICON today announced ICONIK Labs, the latest service to leverage its ICONIK technology platform
ICONIK Patient Safety offers a systematic way to monitor safety trends in accumulating data, spot potential safety issues and take appropriate corrective and preventative action while the study is on-going.
ICON is a finalist in the best CRO and best technological development in clinical trials categories.
ICON today announced the third in its four-part Solution Provider educational webinar series in collaboration with DIA.
ICONIK Monitoring enables the targeted use of monitoring resources by using scientific analysis of real time data, together with CRA site knowledge, to direct central and on-site monitoring activities based on real need.
ICON and the National Clinical Trials and Research Centre (NCTRC) at the National Taiwan University Hospital, today announced a collaboration agreement to enhance the set-up and management of clinical studies in Taiwan.
ICON and the University College Dublin (UCD) School of Medicine & Medical Science today announced the launch of an innovative graduate certificate in clinical research that will enhance the quality of graduate training in clinical research and increase the pool of talent available to ICON to support their clients drug development programmes.
ICON today announced the appointment of Dr. Neil McCullough as Executive Vice President of Quality and Compliance and Corporate Training.